TABLE 2.
Developmental Outcomes
| Cohort, Mean ± SD | Adjusted P (95% CI)a | |||||
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | Cohorts 2–1 | Cohorts 3–1 | Cohorts 3–2 | |
| Evaluations | ||||||
| No. (range) | 2.43 ± 1.45 (1 to 9) | 2.27 ± 1.04 (1 to 7) | 1.38 ± 0.73 (1 to 4) | .77 (−0.7 to 0.4) | <.001 (−1.7 to −0.4) | .02 (−1.7 to −0.1) |
| Chronological age | ||||||
| Initial, mo | 19 ± 10 | 24 ± 16 | 37 ± 19 | .04 (0.3 to 11.6) | <.001 (12.0 to 24.5) | <.001 (4.7 to 19.8) |
| Final, mo | 39 ± 16 | 51 ± 21 | 57 ± 7 | .04 (0.6 to 24.4) | .20 (−7.3 to 44.3) | .85 (−20.6 to 32.7) |
| MSEL | ||||||
| Initial developmental age, mo | 13 ± 6 | 8 ± 5 | 7 ± 6 | <.001 (−8.0 to −2.8) | <.001 (−9.1 to −3.5) | .81 (−4.3 to 2.5) |
| Final developmental age, mo | 18 ± 10 | 11 ± 7 | 8 ± 8 | <.001 (−10.6 to −2.4) | <.001 (−14.5 to −5.4) | .31 (−8.9 to 2.1) |
| VABS | ||||||
| Initial developmental age, mo | 19 ± 13 | 10 ± 7 | 12 ± 10 | .001 (−14.9 to −3.2) | .13 (−13.7 to 1.3) | .72 (−5.8 to 11.6) |
| Final developmental age, mo | 27 ± 20 | 18 ± 22 | 12 ± 10 | .09 (−18.0 to 1.0) | .02 (−26.7 to −1.7) | .61 (−20.2 to 8.7) |
| PLS | ||||||
| Initial raw score | 28 ± 13 | 22 ± 8 | 22 ± 15 | .06 (−13.1 to 0.3) | .13 (−13.8 to 1.4) | 1.00 (−9.1 to 9.5) |
| Final raw score | 50 ± 30 | 40 ± 24 | 27 ± 17 | .18 (−23.7 to 3.3) | .003 (−39.6 to −6.5) | .27 (−32.5 to 6.8) |
| LEAQ | ||||||
| Initial raw score | 7 ± 9 | 7 ± 7 | 2 ± 3 | .97 (−4.8 to 5.9) | .28 (−11.4 to 2.5) | .30 (−13.1 to 3.0) |
| Final raw score | 15 ± 13 | 13 ± 10 | 2 ± 3 | .76 (−8.6 to 4.7) | .002 (−21.9 to −4.3) | .02 (−21.1 to −1.2) |
| PSI | ||||||
| Initial total score | 196 ± 33 | 226 ± 45 | 252 ± 42 | <.001 (11.4 to 48.8) | <.001 (31.4 to 80.5) | .08 (−2.4 to 54.1) |
| Final total score | 200 ± 41 | 227 ± 46 | 252 ± 41 | .007 (6.2 to 47.7) | <.001 (24.1 to 79.2) | .16 (−6.8 to 56.2) |
Cohort 1, normal cognitive skills and adaptive behavior, underwent cochlear implantation, not lost to follow-up (n = 99); cohort 2, EDI, underwent cochlear implantation, not lost to follow-up (n = 32); cohort 3, EDI, hearing aids only, not lost to follow-up (n = 29).
Tukey post hoc subgroup comparisons.